Chordoma
Showing 1 - 25 of 77
Chordoma, Chemo Effect Trial in Beijing (camrelizumab and apatinib)
Recruiting
- Chordoma
- Chemotherapy Effect
- camrelizumab and apatinib
-
Beijing, Beijing, ChinaBEIJING
Nov 14, 2023
Chordoma of Spine, Surgery Trial (Resection surgery)
Not yet recruiting
- Chordoma of Spine
- Surgery
- Resection surgery
- (no location specified)
Jan 27, 2023
Sacral Chordoma Trial in Heidelberg (protons, carbon ions)
Suspended
- Sacral Chordoma
- protons
- carbon ions
-
Heidelberg, GermanyUniversity of Heidelberg, Radiooncology, HIT
Nov 26, 2022
Chordoma Trial in Houston (Proton Beam Therapy, Photon Beam Therapy)
Active, not recruiting
- Chordoma
- Proton Beam Therapy
- Photon Beam Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 5, 2022
A Protocol to Identify Sporadic Chordoma Studies of
Recruiting
- Genes
- Sporadic Chordoma
-
Rockville, MarylandWestat, Inc.
Aug 20, 2022
Multi-parametric Imaging in Personalized Radiotherapy
Recruiting
- Skull Base Chordoma
- diffusion MRI sequences
-
Pavia, Pv, ItalyCNAO
May 24, 2023
Chordoma, Metastatic Chordoma, Unresectable Chordoma Trial in Houston (Cetuximab, Questionnaire Administration)
Recruiting
- Chordoma
- +2 more
- Cetuximab
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Jun 1, 2022
Chordoma Trial in Baltimore, New York (other, biological, radiation)
Active, not recruiting
- Chordoma
- Laboratory Biomarker Analysis
- +2 more
-
Baltimore, Maryland
- +1 more
Oct 3, 2022
Chordoma, Chondrosarcoma, Ewing Sarcoma Trial in Nice (Proteus ONE one daily beam, Proteus ONE two daily beam)
Recruiting
- Chordoma
- +3 more
- Proteus ONE one daily beam
- Proteus ONE two daily beam
-
Nice, FranceCentre Antoine lacassagne
Sep 14, 2023
Chordoma Trial in United States (BN-Brachyury plus radiation)
Completed
- Chordoma
- BN-Brachyury plus radiation
-
Phoenix, Arizona
- +4 more
Feb 25, 2022
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Chordoma, Chondrosarcoma Trial in Madrid (5-fraction hipofractionated protontheray)
Recruiting
- Chordoma
- Chondrosarcoma
- 5-fraction hipofractionated protontheray
-
Madrid, SpainCentro de Protonterapia Quironsalud
May 15, 2023
Skull Base Chordoma, Vertebral Chordoma Trial in Saint-Cloud (procedure, radiation, drug)
Active, not recruiting
- Skull Base Chordoma
- Vertebral Chordoma
- Surgery
- +2 more
-
Saint-Cloud, Ile De France, FranceInstitut Curie - Hôpital René Huguenin
Mar 30, 2022
Chordoma Trial in Boston (Nilotinib, Radiation therapy)
Active, not recruiting
- Chordoma
- Nilotinib
- Radiation therapy
-
Boston, MassachusettsMassachusetts General Hospital
Oct 27, 2021
Chordoma, Breast Cancer, Gastric/Gastroesophageal Junction Cancer Trial in United States (TAEK-VAC-HerBy)
Recruiting
- Chordoma
- +2 more
- TAEK-VAC-HerBy
-
Scottsdale, Arizona
- +8 more
Oct 27, 2022
Image Assisted Optimization of Proton Radiation Therapy in
Recruiting
- Bone Neoplasm of Vertebral Column
- +5 more
-
Delft, South Holland, Netherlands
- +1 more
Apr 5, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Chordoma, Unresectable Malignant Tumor Trial in El Segundo (biological, drug, radiation)
Withdrawn
- Chordoma
- Unresectable Malignant Neoplasm
- Aldoxorubicin Hydrochloride
- +9 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 17, 2021
Chordomas, Chondrosarcomas Trial in Philadelphia (Proton Therapy)
Active, not recruiting
- Chordomas
- Chondrosarcomas
- Proton Therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 2, 2022
Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)
Available
- Pancreatic Cancer
- +6 more
-
Santa Monica, CaliforniaSarcoma Oncology Research Center, LLC
Jan 20, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
Chordoma Trial in Worldwide (Randomized Cohort, Prospective cohort)
Recruiting
- Chordoma
- Randomized Cohort
- Prospective cohort
-
Graz, Austria
- +27 more
Oct 29, 2021
Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)
Recruiting
- Atypical Teratoid/Rhabdoid Tumor
- +17 more
- Atezolizumab
- +7 more
-
Birmingham, Alabama
- +19 more
Feb 2, 2023